Stay updated with breaking news from Sciences Price Performance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
TFO Wealth Partners LLC raised its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 76,466.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,594 shares of the medical research company’s stock after acquiring an additional 4,588 shares during the […]
Applied DNA Sciences, Inc. (NASDAQ:APDN – Get Free Report) saw a large growth in short interest during the month of April. As of April 15th, there was short interest totalling 298,700 shares, a growth of 10.3% from the March 31st total of 270,800 shares. Based on an average daily volume of 150,500 shares, the days-to-cover […]
StockNews.com initiated coverage on shares of Applied DNA Sciences (NASDAQ:APDN – Free Report) in a report published on Monday morning. The brokerage issued a hold rating on the technology company’s stock. Separately, HC Wainwright dropped their price target on Applied DNA Sciences from $40.00 to $30.00 and set a buy rating on the stock in […]
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) was the target of some unusual options trading activity on Tuesday. Investors purchased 16,937 call options on the company. This is an increase of 291% compared to the average volume of 4,328 call options. Insider Activity at Exact Sciences In other Exact Sciences news, CEO Kevin T. […]
Impax Asset Management Group plc trimmed its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 9.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,945 shares of the medical research company’s stock after selling 413 shares during […]